Analysis of complement pathway in dacryoadenitis of programmed cell death-1 deficient mice

被引：0
|
作者：
Sakurai, Yutaka [1 ]
Ito, Masataka [1 ]
Karasawa, Yoko [1 ]
Takeuchi, Masaru [1 ]
机构：
[1] Natl Def Med Collage, Tokoroawa, Saitama, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4925
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Targeting the programmed cell death-1 pathway in breast and ovarian cancer
    Emens, Leisha A.
    Kok, Marleen
    Ojalvo, Laureen S.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2016, 28 (02) : 142 - 147
  • [12] Targeting the programmed death-1 pathway in lymphoid neoplasms
    Ok, Chi Young
    Young, Ken H.
    CANCER TREATMENT REVIEWS, 2017, 54 : 99 - 109
  • [13] Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity
    Niedzwiedzka-Rystwej, Paulina
    Majchrzak, Adam
    Aksak-Was, Bogusz
    Serwin, Karol
    Czajkowski, Zenon
    Grywalska, Ewelina
    Korona-Glowniak, Izabela
    Rolinski, Jacek
    Parczewski, Milosz
    CELLS, 2022, 11 (12)
  • [14] Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer
    Nomi, Takeo
    Sho, Masayuki
    Akahori, Takahiro
    Hamada, Kaoru
    Kubo, Atsushi
    Kanehiro, Hiromichi
    Nakamura, Shinji
    Enomoto, Koji
    Yagita, Hideo
    Azuma, Miyuki
    Nakajima, Yoshiyuki
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 2151 - 2157
  • [15] The Programmed Cell Death-1 Signaling Pathway In Chronic Pulmonary Fungal Infection
    Roussey, J. A.
    Vigilanti, S. P.
    Teitz-Tennenbaum, S.
    Osterholzer, J. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [16] Programmed cell death-1 inhibition in lymphoma
    Hawkes, Eliza A.
    Grigg, Andrew
    Chong, Geoff
    LANCET ONCOLOGY, 2015, 16 (05): : E234 - E245
  • [17] Tumor Progression by Immune Evasion in Melanoma Role of the Programmed Cell Death-1/Programmed Cell Death-1 Ligand 1 Interaction
    Kashani-Sabet, Mohammed
    CANCER, 2010, 116 (07) : 1623 - 1625
  • [18] Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms
    Choi, D. C.
    Tremblay, D.
    Iancu-Rubin, C.
    Mascarenhas, J.
    ANNALS OF HEMATOLOGY, 2017, 96 (06) : 919 - 927
  • [19] Regulation of postsurgical fibrosis by the programmed death-1 inhibitory pathway
    Holsti, MA
    Chitnis, T
    Panzo, RJ
    Bronson, RT
    Yagita, H
    Sayegh, MH
    Tzianabos, AO
    JOURNAL OF IMMUNOLOGY, 2004, 172 (09): : 5774 - 5781
  • [20] Programmed Death-1 Pathway in Orbital Invasion of Cutaneous Carcinomas
    Wladis, Edward J.
    Lee, Joshua A.
    Carlson, J. Andrew
    Martino, Nina
    Adam, Alejandro P.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2018, 34 (02): : 110 - 113
12345